Optimal Systemic Treatment for Early Triple-Negative Breast Cancer.

Furlanetto, Jenny; Loibl, Sibylle

Furlanetto, Jenny; Loibl, Sibylle.

Affiliation

Furlanetto J; GBG Forschungs GmbH, Neu Isenburg, Germany.
Loibl S; GBG Forschungs GmbH, Neu Isenburg, Germany.

Breast Care (Basel) ; 15(3): 217-226, 2020 Jun.

Article in En | MEDLINE | ID: mdl-32774215

Key words

Early breast cancer; Guidelines; Treatment; Triple-negative breast cancer

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383279
https://dx.doi.org/10.1159/000508759

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Type of study: Guideline Language: En Journal: Breast Care (Basel) Year: 2020 Type: Article Affiliation country: Germany

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383279
https://dx.doi.org/10.1159/000508759

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Type of study: Guideline Language: En Journal: Breast Care (Basel) Year: 2020 Type: Article Affiliation country: Germany